Medtronic plc
MDT · NYSE
10/24/2025 | 7/25/2025 | 4/30/2025 | 1/24/2025 | |
|---|---|---|---|---|
| Market Cap | $120,066 | $119,112 | $108,688 | $115,660 |
| - Cash | $1,282 | $1,273 | $2,218 | $1,240 |
| + Debt | $29,100 | $28,609 | $28,516 | $26,607 |
| Enterprise Value | $147,884 | $146,448 | $134,986 | $141,027 |
| Revenue | $8,961 | $8,578 | $8,927 | $8,292 |
| % Growth | 4.5% | -3.9% | 7.7% | – |
| Gross Profit | $5,405 | $4,946 | $5,780 | $5,513 |
| % Margin | 60.3% | 57.7% | 64.7% | 66.5% |
| EBITDA | $2,366 | $2,225 | $2,275 | $2,403 |
| % Margin | 26.4% | 25.9% | 25.5% | 29% |
| Net Income | $1,374 | $1,040 | $1,057 | $1,294 |
| % Margin | 15.3% | 12.1% | 11.8% | 15.6% |
| EPS Diluted | 1.07 | 0.81 | 0.82 | 1.01 |
| % Growth | 32.1% | -1.2% | -18.8% | – |
| Operating Cash Flow | $925 | $1,088 | $2,528 | $2,572 |
| Capital Expenditures | -$468 | -$504 | -$459 | -$476 |
| Free Cash Flow | $457 | $584 | $2,069 | $2,096 |